"All types of patients may benefit from this treatment, even those with other chronic medical conditions," said Bharati Prasad, MD, MS, the study's principal investigator. "It's important to now do a prospective study enrolling different types of patients with sleep apnea."
The study, appearing in the Oct. 15 issue of the Journal of Clinical Sleep Medicine, examined the effectiveness of obstructive sleep apnea treatment on high blood pressure and diabetes control in 221 men with preexisting hypertension or type 2 diabetes and a new diagnosis of OSA. Participants received positive airway pressure (PAP) therapy upon treatment initiation.
Results show that both systolic and diastolic blood pressure decreased significantly with initiation of OSA treatment at both the first follow-up, 3-6 months after initiation, and the second follow-up, 9-12 months later.
According to the authors, this is the first study to examine the effectiveness of treatment of obstructive sleep apnea on routine measures of hypertension and diabetes control in a practice-based clinical setting. The results show the real-world effectiveness of OSA treatment on hypertension.
Keywords for this news article include: Diabetes, Pulmonology, Craniofacial, Hypertension, Blood Pressure, Otolaryngology, Sleep Disorders, Respiration Disorders, Cardiovascular Diseases, Obstructive Sleep Apnea, Respiratory Tract Diseases, American Academy of Sleep Medicine.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.